A substituted drug-test result means the laboratory found the urine specimen was not consistent with normal human urine. An adulterated result means the laboratory found something that interfered with testing, while dilute and invalid describe different laboratory findings. For DOT-regulated tests, a verified substituted or adulterated result is treated as a refusal to test.
The important next step is to understand the exact result, who reported it, and which rules apply to your job or program. A collection-site concern and a final laboratory/MRO result are not the same thing.
| Substituted | The laboratory found the specimen was not consistent with normal human urine. |
| Adulterated | The laboratory found a substance or condition that interfered with the test. |
| Dilute | The specimen was more diluted than the DOT laboratory criteria describe; it is a separate result from substituted. |
| Invalid | The laboratory could not report the specimen as a standard valid result and reports the reason to the MRO. |
| DOT consequence | A verified substituted or adulterated result is a refusal to test under 49 CFR 40.191. |
| Immediate focus | Speak with the MRO promptly and keep the notice, chain-of-custody information, and your employer policy. |
What does substituted mean on a drug test?
In plain words, substituted means the laboratory reported that the urine sample did not have the characteristics expected of normal human urine. In a DOT test, the laboratory performs specimen-validity testing and reports its finding to the Medical Review Officer, or MRO.
The MRO must tell you whether the laboratory reported a positive, adulterated, substituted, or invalid result and explain the basis for that finding during the verification interview. 49 CFR 40.135 sets out that conversation. The collector may record what happened at the collection site, but the employer has the final responsibility for deciding whether conduct was a refusal in the situations covered by the DOT rules.
For a cannabis-related result, the result category still matters separately from the substance being tested. MRO review and confirmation explains the difference between screening, confirmation, and review.
How are substituted, adulterated, dilute, and invalid results different?
| Result | What it means in plain language | What may happen next in DOT testing |
|---|---|---|
| Substituted | The laboratory determined that the specimen was not consistent with normal human urine. | The MRO reviews and verifies the result. A verified substituted result is a refusal to test. |
| Adulterated | The laboratory found an interfering substance or condition in the specimen. | The MRO reviews and verifies the result. A verified adulterated result is a refusal to test. |
| Dilute | The laboratory reports a specimen as dilute under its validity criteria. This does not mean substituted. | DOT rules can require another collection in particular circumstances. |
| Invalid | The laboratory cannot report a standard valid result and must state the reason for the invalid finding. | The MRO follows the applicable invalid-result process; an immediate directly observed recollection can be required in some cases. |
These terms are laboratory result categories, not guesses based on how a sample looks. Under the DOT process, the collector checks the specimen when it is presented and the laboratory also processes the specimen under federal procedures. The collection rules require the collector to inspect for signs of tampering and take further steps when required. 49 CFR 40.65 describes those collection-site checks, while 49 CFR 40.83 covers laboratory processing.
A common question is why a collector says not to flush. In the DOT urine-collection process, the collector directs the employee not to flush and to return with the specimen immediately after voiding. That is part of the collection procedure, not a result by itself. 49 CFR 40.63 explains the rule.
What are the consequences of a substituted or adulterated result?
For DOT-regulated work: as of October 15, 2026, a verified substituted or adulterated result is a refusal to test under 49 CFR 40.191. The consequences come from the DOT agency rules that apply to the job. The regulation also says those DOT refusal consequences cannot be overturned by an arbitration, grievance, state court, or other non-federal forum deciding the employer’s personnel action.
For a non-DOT test: the employer’s written policy, contract, union agreement, and applicable state law matter. A refusal of a non-DOT test is not, by itself, a DOT refusal. Read the document that applied to your test before assuming that a DOT rule controls the outcome. Federal and non-federal tests can help you sort out which system applies.
State cannabis employment rules can also affect particular workplace decisions, but they do not replace federal DOT testing rules. For example, California’s employment law has specific cannabis-related protections and exceptions, while Illinois permits employers to adopt reasonable workplace drug policies. Those are state-specific rules, not a nationwide result rule.
Can you dispute the result or ask for another test?
Start with the MRO named in your notice. Ask what result was reported, the basis the MRO will consider, and what deadline applies. In a DOT test, an employee notified of a verified positive or a refusal because of adulteration or substitution has 72 hours to request a split-specimen test. The request can be verbal or written. There is no split-specimen testing for an invalid result. 49 CFR 40.171 explains the process.
The MRO process has limits. For example, DOT rules say the MRO does not decide factual disputes about collection-site events that are not reflected on the custody form, or whether the employer should have ordered the test. Those may be questions for HR, a union representative, or an employment lawyer, depending on your situation.
If your concern is a THC result rather than specimen validity, read Delta 9 and drug tests and Delta-8 lab detection. Under DOT’s CBD notice (February 18, 2020), CBD use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive, and MROs verify such a result as positive even if the employee says they only used a CBD product.
What should you do after this result?
- Keep the paperwork. Save the notice, custody form, result communication, employer policy, and dates of every call.
- Contact the MRO promptly. Ask for the exact reported category and the deadline for any available response or split-specimen request.
- Read the policy for this test. Check whether it was DOT-regulated, pre-employment, random, post-incident, or another type of test.
- Use the right support. HR can explain the employer process; a union representative can explain any applicable agreement; an employment lawyer can advise on your situation and state law.
Are synthetic urine and test-interference products legal?
There is no single federal statute that bans synthetic urine nationwide. But federal DOT rules treat a verified substituted or adulterated specimen as a refusal to test, and state laws can separately restrict products or conduct intended to falsify a drug or alcohol test.
As of October 15, 2026, state rules differ. Iowa explicitly prohibits manufacturing, marketing, selling, distributing, using, or possessing synthetic urine or urine additives for the purpose of defrauding a test. Iowa Code 715A.11 sets separate first and subsequent-offense penalties.
Other statutes use broader language. Florida prohibits willfully defrauding, or attempting to defraud, a lawfully administered urine test and prohibits making, advertising, selling, or distributing a substance or device intended for that purpose. Florida Statute 817.565 states that violation is a first-degree misdemeanor. Texas prohibits using or possessing with intent to use a substance or device designed to falsify drug-test results, with separate provisions for delivery or manufacture. Texas Health and Safety Code 481.133 states the applicable offense levels.
Some products are labeled as novelty or calibration items. That label does not change the DOT result rules or the state statute that may apply where you live or work. If a test or result could affect your job, get advice about the exact state and employment setting before acting.
Before you respond to the notice
- Ask whether your result was substituted, adulterated, dilute, invalid, positive, cancelled, or rejected for testing.
- Ask whether an MRO verification interview or split-specimen request applies and when the deadline expires.
- Ask HR for the written policy that governed the test and any reconsideration process.
- For DOT-covered work, ask how the applicable agency rule handles a verified refusal.
For a broader look at cannabis products and testing questions, see Delta-8 safety and tests. This is general information, not legal advice. Deadlines can be short, so someone facing a test or result can talk with the MRO for a regulated test, HR, a union representative, or an employment lawyer.
By HealthDataConsortium.org Research Team
